FDA Clears Roche and Eli Lilly's Blood Test to Aid in Alzheimer's Disease Identification
The U.S. Food and Drug Administration (FDA) has cleared Roche and partner Eli Lilly's Elecsys pTau217 blood test. This biomarker test is designed to help identify signs of Alzheimer's disease in individuals aged 55 and older experiencing cognitive decline.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.